Radcliffe Capital Management, L.P. - MONTEREY BIO ACQUISITION COR ownership

MONTEREY BIO ACQUISITION COR's ticker is and the CUSIP is 61240F116. A total of 34 filers reported holding MONTEREY BIO ACQUISITION COR in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of MONTEREY BIO ACQUISITION COR
ValueSharesWeighting
Q3 2023$5,000
-12.7%
200,0000.0%0.00%
Q2 2023$5,730
+0.5%
200,0000.0%0.00%
Q1 2023$5,700
-99.7%
200,0000.0%0.00%
-100.0%
Q4 2022$2,100,000
+3.9%
200,0000.0%0.07%
+34.7%
Q3 2022$2,022,000
+0.9%
200,0000.0%0.05%
+6.5%
Q2 2022$2,004,000
+0.6%
200,0000.0%0.05%
+2.2%
Q1 2022$1,993,000
+0.9%
200,0000.0%0.04%
-13.5%
Q4 2021$1,975,000200,0000.05%
Other shareholders
MONTEREY BIO ACQUISITION COR shareholders Q1 2023
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 500,000$4,980,0000.27%
BOOTHBAY FUND MANAGEMENT, LLC 384,993$3,835,0000.09%
Radcliffe Capital Management, L.P. 200,000$1,993,0000.04%
EHP Funds Inc. 895,644$194,0000.03%
Murchinson Ltd. 500,000$108,0000.02%
ATW SPAC MANAGEMENT LLC 384,993$84,0000.01%
MMCAP International Inc. SPC 625,000$136,0000.01%
K2 PRINCIPAL FUND, L.P. 400,000$87,0000.01%
BASSO CAPITAL MANAGEMENT, L.P. 224,096$49,0000.01%
CVI Holdings, LLC 218,685$47,0000.00%
View complete list of MONTEREY BIO ACQUISITION COR shareholders